IMAGE: E. coli has been reprogrammed to produce chondroitin sulfate, a complex sugar. view more
Credit: Rensselaer Polytechnic Institute
TROY, NY – By imagining an animal-free drug supply, scientists – for the first time – reprogrammed a common bacteria to create an engineered polysaccharide molecule used in pharmaceuticals and nutraceuticals. Posted today in Nature Communications, researchers modified E. coli to produce chondroitin sulfate, a drug best known as a dietary supplement to treat arthritis that currently originates in the trachea of cows.
Genetically modified E. coli is used to make a long list of medicinal proteins, but it has taken years to persuade bacteria to produce even the simplest of this class of linked sugar molecules – called sulfated glycosaminoglycans – which are often used as drugs and nutraceuticals. .
“It’s an E. coli engineering challenge to produce these molecules, and we had to make a lot of changes and balance those changes for the bacteria to grow well,” said Mattheos Koffas, senior researcher and professor of chemical engineering. and organic at Rensselaer Polytechnic Institute. “But this…
Read Additional From Source
Copyright @ www.eurekalert.org
News Highlights Science
- According to the source Common bacteria modified to make a drug based on sugar
- Check all news and articles from the Science news information updates.